lamivudine has been researched along with Sensitivity and Specificity in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (7.14) | 18.2507 |
2000's | 74 (66.07) | 29.6817 |
2010's | 30 (26.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, X; Geleziunas, R; Hesselgesser, J; Jin, H; Jones, GS; Kim, CU; Tsiang, M; Wright, M; Yu, F; Zeynalzadegan, A | 1 |
Amara, A; Diliiy Penchala, S; Else, L; Khoo, S; Lamorde, M; Olagunju, A; Waitt, C | 1 |
Cathcart, AL; Delaney, WE; Kitrinos, KM; Liu, Y | 1 |
Long, L; Su, J; Zou, K | 1 |
Bärnighausen, TW; Geldsetzer, P; Gómez-Olivé, FX; Harling, G; Kahn, K; Manne-Goehler, J; Montana, L; Rohr, J; Siedner, M; Tollman, S; Wagner, R; Wiesner, L | 1 |
Babu, KN; Kumar, BR; Kumar, VR; Reddy, BP; Sreekanth, K | 1 |
Bhattacharya, D; Bickel, M; Knecht, G; Lassmann, B; Lewis, MJ; Phan, T; Yang, OO | 1 |
B, PB; Kilaru, NB; S, KS; V, PK; Valluru, RK | 1 |
Abaci, N; Arikan, M; Badur, S; Bozkaya, E; Cakiris, A; Gumus, E; Kaymakoglu, S; Kursun, O; Mese, S; Onel, D; Ustek, D; Yenen, OS | 1 |
Chang, K; Chen, M; Deng, S; Jia, S; Jiang, W; Li, F; Shang, Y; Wang, F; Yang, S; Zhang, K | 1 |
Cai, SH; Jiang, YG; Lv, FF; Peng, J; Zhang, YH | 1 |
Jang, JY; Kim, BH; Kim, JW; Lee, CK; Shim, JJ | 1 |
Chen, J; Chen, X; Lin, J; Ou, Q; Shang, H; Su, M; Wu, S; Wu, Y; Yang, B; Zeng, Y | 1 |
Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
Fung, J; Lai, CL; Wong, DK; Yuen, MF | 1 |
Hsi, J; Liao, L; Liu, J; Pan, X; Ruan, Y; Shao, Y; Su, B; Wang, Z; Wu, J; Xing, H; Yan, J; Zhang, J | 1 |
Chan, HL; Chan, HY; Chim, AM; Sung, JJ; Wong, GL; Wong, VW | 1 |
Chen, DS; Chen, PJ; Chou, WP; Liu, CJ; Lu, SF; Shih, YH; Wang, HY; Yeh, SH | 1 |
Creaser, CS; Eckers, C; Howdle, MD; Laures, AM | 1 |
Degertekin, B; Hussain, M; Lok, AS; Oberhelman, K; Tan, J | 1 |
Bedse, G; Kumar, V; Singh, S | 1 |
Barguès, G; Boyer, V; Germi, R; Hilleret, MN; Larrat, S; Leroy, V; Lupo, J; Morand, P; Nicod, S; Seigneurin, JM; Zarski, JP | 1 |
Adams, E; Baert, L; Hoogmartens, J; Pendela, M; Rosier, J; Van den Mooter, G; Van Gyseghem, E | 1 |
Ishikawa, H; Kaneko, S; Katayama, M; Matsuda, Y; Miyaji, K; Suzuki, K; Takamatsu, K | 1 |
Hu, L; Kong, H; Lu, F; Luo, Y; Pickerill, S; Shi, J; Wang, H; Xu, G; You, P; You, Q; Zhong, H | 1 |
Choi, JJ; Jang, H; Kim, J; Park, H; Son, Y | 1 |
Aung, MO; Dan, YY; Fernandes, M; Koay, E; Lee, GH; Lee, YM; Lim, LG; Lim, SG; Seet, BL; Sutedja, DS; Tan, C | 1 |
Goswami, S; Pande, UC; Sanyal, M; Shrivastav, PS; Singhal, P; Yadav, M | 1 |
Asaka, M; Chuma, M; Hige, S; Horimoto, H; Kobayashi, T; Nakanishi, M; Natsuizaka, M; Sho, T; Yamamoto, K; Yamamoto, Y; Yoshida, S | 1 |
Dejaegher, B; Kaale, E; Risha, PG; Shewiyo, DH; Sigonda, MN; Smeyers-Verbeke, J; Ugullum, C; Vander Heyden, Y | 1 |
Egashira, T; Kobayashi, M; Kumada, H; Nagano, M; Suzuki, F; Tadokoro, K; Yamaguchi, T | 1 |
Awen, BZ; Challa, BR; Chandu, BR; Rihanaparveen, S | 1 |
Anderson, PL; Bushman, LR; Klein, B; Rower, JE | 1 |
Anderson, PL; Bushman, LR; Kiser, JJ; Klein, B; Ray, ML; Rower, JE; Zheng, JH | 1 |
Ağca, H; Akarsu, M; Sayıner, AA; Sengönül, A; Simşek, I | 1 |
Feng, C; Li, J; Lou, GQ; Wu, LJ; Wu, NP; Yang, J | 1 |
Burugula, L; Inamadugu, JK; J V L N, SR; Matta, MK; Pilli, NR | 1 |
Aleti, R; Bhyrapuneni, G; Kalaikadhiban, I; Kandikere, V; Komarneni, P; Muddana, N; Nirogi, R; Padala, N | 1 |
Cheng, H; Shen, J; Wu, B | 1 |
Daimon, Y; Itoh, Y; Kirishima, T; Minami, M; Morita, A; Nakamura, H; Okanoue, T; Toyama, T | 1 |
Bartlett, MG; Fan, B; Stewart, JT | 1 |
Alcoba-Leza, M; Carro-Fernández, JA; Cuevas-González, MJ; Martín-Sánchez, V; Mostaza-Fernández, JL; Ortega-Valín, L; Ortiz de Urbina-González, JJ; Pérez-Simón, Mdel R; Rodríguez-María, M | 1 |
Estrela, Rde C; Raices, RS; Salvadori, MC; Suarez-Kurtz, G | 1 |
Aoyagi, Y; Ichida, T; Kitajima, I; Ogata, N | 1 |
Aslan, N; Bozdayi, AM; Bozdayi, G; Bozkaya, H; Cinar, K; Karayalçin, S; Pai, R; Pai, SB; Sahin, T; Schinazi, RF; Sezgin, O; Türkyilmaz, AR; Uzunalimoğlu, O; Yurdaydin, C | 1 |
Chen, Y; Hu, YY; Jiang, JJ; Li, D; Li, QG; Lin, CW | 1 |
Hino, T; Hisamochi, A; Ide, T; Koga, Y; Kumashiro, R; Kuwahara, R; Murashima, S; Ogata, K; Sata, M; Tanaka, E; Tanaka, K | 1 |
Bai, YJ; Lv, GT; Wang, Y; Yan, XJ; Zhang, WH; Zhao, JR | 1 |
Bonard, D; Dabis, F; Ekouévi, DK; Huet, C; Minga, A; Rouet, F; Rouzioux, C; Salamon, R; Toni, TA | 1 |
Estrela, Rde C; Salvadori, MC; Suarez-Kurtz, G | 1 |
Cho, M; Heo, J; Jang, HJ; Kang, DH; Kim, CM; Kim, GH; Kim, HH; Park, HK; Shin, YM; Song, GA; Yang, US | 1 |
Cho, B; Cho, M; Heo, J; Jang, H; Jun, H; Kim, C; Kim, H; Park, H; Shin, W | 1 |
Alnouti, Y; Bartlett, MG; White, CA | 1 |
Aarnoutse, RE; Burger, DM; Verweij-van Wissen, CP | 1 |
Chen, LY; Huang, J; Li, ZG; Qiao, P; Qiu, JM; Wang, SQ | 1 |
Bang, SJ; Joo, KR; Kim, DH; Park, JH; Park, NH; Shin, JW | 1 |
Bergroth, T; Sönnerborg, A; Yun, Z | 1 |
Dulai, GS; Farid, M; Gralnek, IM; Kanwal, F; Martin, P; Spiegel, BM | 1 |
Bowden, S; Chan, HL; Hui, AY; Leung, NW; Liew, CT; Locarnini, S; Sung, JJ; Wong, ML; Wong, VW | 1 |
Cao, Y; Geng, H; Hua, B; Sun, Y; Wang, H; Yu, A | 1 |
Chen, LY; Geng, YY; Huang, J; Liu, HJ; Qiao, P; Qiu, JM; Wang, SQ; Yang, NM; Zhang, W; Zhang, XP | 1 |
Attanasio, V; Eriksson, T; Finnström, N; Hedrum, A; Marrone, A; Rosario, P; Ruggiero, G; Törmänen, V; Utili, R; Zampino, R | 1 |
Chen, CJ; Cheng, G; He, YS; Liu, N; Ou, ZY | 1 |
Akarca, US; Erensoy, S; Niesters, HG; Ozacar, T; Ozgenc, F; Pas, S; Sertoz, RY; Yamazhan, T | 1 |
Chayama, K; Iino, S; Imamura, M; Kawata, S; Kimura, T; Kiyosawa, K; Kobayashi, M; Maki, N; Matsumoto, A; Minami, M; Mizokami, M; Nagaoka, S; Okanoue, T; Suzuki, F; Tanaka, E; Tanaka, Y; Yatsuhashi, H; Yotsuyanagi, H | 1 |
Kapoor, N; Khandavilli, S; Panchagnula, R | 1 |
Andreone, P; Cursaro, C; Fung, S; Hussain, M; Libbrecht, E; Lok, AS; Sablon, E | 1 |
Han, B; Wang, RS; Yang, ZJ; Zhang, H; Zhu, YF | 1 |
Awi, D; Kaye, S; McConkey, SJ; Mendy, ME; Rayco-Solon, P; Shipton, D; Snell, P; van der Sande, M; Waight, PA; Whittle, H | 1 |
Jin, LJ; Lin, QY; Shi, M; Wang, RS; Xu, YP; Yang, ZJ; Zhang, H; Zhu, YF | 1 |
Olatunji, PO; Olawumi, HO | 1 |
Fujioka, S; Iwasaki, Y; Kobashi, H; Matsumura, M; Sakaguchi, K; Shiraha, H; Shiratori, Y; Takaki, A; Tatsukawa, M; Umeoka, F | 1 |
Huang, GT; Lee, CZ; Lee, HS; Sheu, JC; Yang, PM | 1 |
Bang, SJ; Jeong, ID; Jung, SW; Kim, BC; Kim, DH; Kwon, SH; Park, JS; Park, NH; Shin, JW | 1 |
Allice, T; Cerutti, F; Colucci, G; Franchello, A; Gabella, S; Ghisetti, V; Marzano, A; Pittaluga, F; Varetto, S | 1 |
Chang, ML; Hsu, CW; Liaw, YF; Yeh, CT | 1 |
Cimerman, S; Diaz, RS; Lewi, DS; Sucupira, MC | 1 |
Li, Q; Wen, H | 1 |
Eckers, C; Giles, K; Laures, AM; Major, H; Pringle, S | 1 |
Brun, SC; Coffin, JM; Davey, RT; Dewar, R; Hanna, GJ; Kempf, DJ; King, MS; Kovacs, JA; Liu, S; Maldarelli, F; Mellors, JW; Metcalf, JA; Mican, J; Palmer, S; Polis, MA; Rehm, C; Rock-Kress, D; Wiegand, A | 1 |
Hannoun, C; Lindh, M; Malmström, S | 1 |
Jadon, N; Jain, R; Radhapyari, K | 1 |
Cho, YK; Jeon, WK; Kim, BI; Kim, YJ; Park, H; Woo, HY | 1 |
Apte, SS; Jukanti, R; Kandikere, V; Kishan, V; Maurya, S; Mudigonda, K; Nirogi, R | 1 |
Aledort, JE; Dusheiko, GM; Jacobs, M; Lewis, G; Patel, KK; Sullivan, SD; Veenstra, DL | 1 |
Abdel-Megeed, MF; Kashuba, AD; Rezk, NL | 1 |
Chan, HL; Chan, HY; Chim, AM; Sung, JJ; Tse, AM; Tse, CH; Wong, GL; Wong, VW | 1 |
Ariyoshi, K; Auwanit, W; Kannagi, M; Matsuda, M; Pathipvanich, P; Rojanawiwat, A; Saeng-Aroon, S; Sawanpanyalert, P; Sugiura, W; Taguchi, M; Yoshida, LM | 1 |
Jin, HZ; Wang, X; Wang, XL; Xie, SG; Yang, WX; Zhang, L | 1 |
Asaka, M; Chiba, H; Chuma, M; Fujisawa, S; Hige, S; Kitamura, T; Nishimura, M; Sato, K; Yamashita, N; Yoshida, M; Yoshida, S | 1 |
Chun, JY; Kim, JK; Kim, MH; Ko, SY; Lee, HJ; Lee, IK; Lee, YJ; Lim, YS; Oh, HB; Suh, DJ | 1 |
Daniel, MJ; Gray, MR; Jenner, WN; Newman, JJ; O'Neill, RM; Sutherland, DR; Wells, GN; Williams, JL; Wring, SA | 1 |
Evans, GL; Harker, AJ; Hawley, AE; Morris, DM | 1 |
Hsyu, PH; Lloyd, TL | 1 |
Sommadossi, JP; Zhou, XJ | 1 |
Heijtink, RA; Honkoop, P; Hop, WC; Kruining, J; Kuhns, MC; Osterhaus, AD; Schalm, SW | 1 |
Edelstein, RE; Frenkel, LM; Manns-Arcuino, LA; Nickerson, DA; Tobe, VO | 1 |
Beijnen, JH; Hoetelmans, RM; Mennhorst, PL; Mulder, JW; Profijt, M | 1 |
Allen, MI; Baldanti, F; Bourne, EJ; Carrick, KM; Condreay, LD; DesLauriers, M; Gauthier, J; Lutz, MW; Ross, LL | 1 |
De Man, RA; Fries, E; Niesters, HG; Osterhaus, AD; Pas, SD | 1 |
Darque, A; Moore, JD; Sommadossi, JP; Valette, G; Zhou, XJ | 1 |
Parkin, N; Resch, W; Stuelke, EL; Swanstrom, R; Watkins, T | 1 |
Buti, M; Cotrina, M; Esteban, R; Guardia, J; Jardi, R; Rodríguez, F; Sánchez, F | 1 |
Chang, TT; Cheng, PN; Jen, CM; Kao, AW; Young, KC | 1 |
Chen, RW; Koskela, P; Lappalainen, M; Piiparinen, H; Sarna, S; Seppänen, M | 1 |
Emm, TA; Wu, ST; Zheng, JJ | 1 |
Bowden, S; Lau, GK; Lewin, SR; Locarnini, S; Perelson, AS; Ribeiro, RM; Walters, T | 1 |
Akanmu, AS; Akinsete, I; Davies, AO; Eshofonie, AO; Okany, CC | 1 |
Hatakeyama, K; Ichida, T; Sato, Y | 1 |
Schechter, M | 1 |
Cho, SW; Hahm, KB; Kim, HJ; Kim, JH; Kim, SW; Lee, KM | 1 |
2 review(s) available for lamivudine and Sensitivity and Specificity
Article | Year |
---|---|
Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.
Topics: Antirheumatic Agents; Antiviral Agents; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reproducibility of Results; Rheumatic Diseases; Risk; Sensitivity and Specificity; Virus Activation | 2018 |
HIV vaccine evaluation center in Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; AIDS Vaccines; Anti-HIV Agents; Behavior Therapy; Bisexuality; Brazil; Clinical Trials, Phase II as Topic; Disease Transmission, Infectious; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV Seropositivity; Homosexuality; Humans; Incidence; Lamivudine; Male; Middle Aged; Safety; Sensitivity and Specificity; Zidovudine | 2002 |
12 trial(s) available for lamivudine and Sensitivity and Specificity
Article | Year |
---|---|
Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
Topics: Adenine; Adult; Anti-Retroviral Agents; Chromatography, Liquid; Cross-Over Studies; Deoxycytidine; Drug Stability; Emtricitabine; Humans; India; Lamivudine; Least-Squares Analysis; Male; Middle Aged; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir; Therapeutic Equivalency | 2010 |
Determination of didanosine in human serum by on-line solid-phase extraction coupled to high-performance liquid chromatography with electrospray ionization tandem mass spectrometric detection: application to a bioequivalence study.
Topics: Administration, Oral; Calibration; Chromatography, High Pressure Liquid; Didanosine; Humans; Lamivudine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Therapeutic Equivalency | 2003 |
YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine.
Topics: Adult; Aged; Antiviral Agents; Base Sequence; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Pharmacogenetics; Polymerase Chain Reaction; Reference Values; Sensitivity and Specificity | 2003 |
Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cote d'Ivoire; Drug Combinations; Enzyme-Linked Immunosorbent Assay; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Prospective Studies; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Zidovudine | 2003 |
A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection.
Topics: Adult; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Cross-Over Studies; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Therapeutic Equivalency; Zidovudine | 2004 |
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.
Topics: Adult; Antiviral Agents; DNA, Circular; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Male; Polyethylene Glycols; Polymerase Chain Reaction; Predictive Value of Tests; Recombinant Proteins; Sensitivity and Specificity; Treatment Outcome | 2005 |
Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B.
Topics: DNA Probes; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Genes, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Sequence Analysis, DNA | 2005 |
The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients.
Topics: Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Serum Albumin; Severity of Illness Index; Stavudine; Treatment Outcome | 2006 |
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia.
Topics: Anti-HIV Agents; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Stavudine; Viremia; Virus Replication | 2007 |
Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.
Topics: Adult; Antiviral Agents; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Health Care Costs; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Markov Chains; Models, Econometric; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Sensitivity and Specificity; United Kingdom | 2007 |
Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
Topics: Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Male; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Treatment Outcome | 2007 |
Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Monitoring; Female; Genetic Variation; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Luminescent Measurements; Male; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Time Factors; Viral Load | 2001 |
98 other study(ies) available for lamivudine and Sensitivity and Specificity
Article | Year |
---|---|
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.
Topics: Anti-HIV Agents; Catalytic Domain; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Synergism; HIV Integrase; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Molecular Structure; Mutation; Protein Structure, Tertiary; Recombinant Proteins; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; T-Lymphocytes | 2009 |
Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Chromatography, Liquid; Cohort Studies; Dried Blood Spot Testing; Emtricitabine; Female; Humans; Infant; Lamivudine; Linear Models; Milk, Human; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir; Young Adult | 2017 |
Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment.
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Polymerase Chain Reaction; Sensitivity and Specificity; Seroconversion; Tenofovir; Viral Load; Virus Replication | 2017 |
ART Denial: Results of a Home-Based Study to Validate Self-reported Antiretroviral Use in Rural South Africa.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Cohort Studies; Emtricitabine; Female; HIV Antibodies; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Rural Population; Self Report; Sensitivity and Specificity; Social Stigma; South Africa; Surveys and Questionnaires; Viral Load | 2019 |
High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma.
Topics: Anti-HIV Agents; Chromatography, Liquid; Humans; Lamivudine; Male; Nevirapine; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Zidovudine | 2013 |
Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach.
Topics: Alleles; Antiviral Agents; DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Evasion; Lamivudine; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mutation; Oligonucleotide Probes; Sensitivity and Specificity | 2013 |
High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.
Topics: Adenine; Chromatography, High Pressure Liquid; Humans; Lamivudine; Linear Models; Male; Nevirapine; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir | 2013 |
Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Molecular Diagnostic Techniques; Mutation; Nucleosides; Nucleotides; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Sequence Analysis, DNA | 2013 |
Rapid detection of hepatitis B virus variants associated with lamivudine and adefovir resistance by multiplex ligation-dependent probe amplification combined with real-time PCR.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Mutation; Organophosphonates; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Time | 2014 |
Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.
Topics: Adenine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Prospective Studies; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Viral Load; Young Adult | 2014 |
Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B.
Topics: Administration, Oral; Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Arabinofuranosyluracil; Biomarkers; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2014 |
Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis B.
Topics: Adult; Aged; Antiviral Agents; DNA Primers; DNA, Viral; Female; Genetic Variation; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2015 |
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors | 2016 |
COLD-PCR for early detection of hepatitis B virus antiviral drug resistance mutations.
Topics: Antiviral Agents; Cold Temperature; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Telbivudine; Thymidine | 2015 |
Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; CD4 Lymphocyte Count; China; Chromatography, Liquid; Cross-Sectional Studies; Drug Monitoring; Drug Resistance, Viral; Female; Hair; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Sensitivity and Specificity; Tandem Mass Spectrometry; Treatment Failure; Viral Load | 2016 |
Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Predictive Value of Tests; Prognosis; Recombinant Proteins; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2008 |
Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis.
Topics: Adult; Amino Acid Motifs; Antiviral Agents; Base Sequence; Drug Resistance, Viral; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Transition Temperature | 2008 |
The use of shift reagents in ion mobility-mass spectrometry: studies on the complexation of an active pharmaceutical ingredient with polyethylene glycol excipients.
Topics: Algorithms; Anti-HIV Agents; Cations; Chemistry, Pharmaceutical; Drug Combinations; Excipients; Lamivudine; Polyethylene Glycols; Protons; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Zidovudine | 2009 |
Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
Topics: Adenine; Adult; Antiviral Agents; DNA Probes; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Sensitivity and Specificity | 2009 |
Study of forced decomposition behavior of lamivudine using LC, LC-MS/TOF and MS(n).
Topics: Chromatography, Liquid; Drug Contamination; Drug Stability; Guidelines as Topic; Hydrogen-Ion Concentration; Hydrolysis; Lamivudine; Light; Mass Spectrometry; Molecular Structure; Oxidation-Reduction; Oxidative Stress; Photolysis; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2009 |
Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
Topics: Adenine; Antiviral Agents; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Plasmids; Polymerase Chain Reaction; Sensitivity and Specificity | 2009 |
Development of a liquid chromatographic assay for an anti-HIV tablet containing lamivudine, zidovudine and TMC278.HCL.
Topics: Anti-HIV Agents; Biological Assay; Calibration; Chemistry, Pharmaceutical; Chromatography, Liquid; HIV; Humans; Lamivudine; Light; Molecular Structure; Nitriles; Pyrimidines; Reference Standards; Rilpivirine; Scattering, Radiation; Sensitivity and Specificity; Solvents; Spectrophotometry, Ultraviolet; Tablets; Zidovudine | 2009 |
Improvement of sensitivity and selectivity of high-performance liquid chromatography for anti-retroviral drugs (non-reverse transcriptase inhibitors) by diamond-electrode electrochemical and fluorescence detection.
Topics: Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Didanosine; Dideoxynucleosides; Electrochemical Techniques; Fluorescence; Humans; Lamivudine; Linear Models; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Water; Zidovudine | 2009 |
Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Ligase Chain Reaction; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reagent Strips; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2010 |
Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Organophosphonates; Peptide Nucleic Acids; Point Mutation; Sensitivity and Specificity | 2010 |
Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistance.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Asian People; Biomarkers; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2010 |
Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acids.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Mutation; Oligonucleotide Probes; Peptide Nucleic Acids; Sensitivity and Specificity | 2010 |
Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets.
Topics: Anti-HIV Agents; Calibration; Chromatography, Thin Layer; Densitometry; Drug Combinations; Humans; Lamivudine; Nevirapine; Reproducibility of Results; Sensitivity and Specificity; Stavudine; Tablets | 2011 |
Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Viral Proteins | 2011 |
LC-ESI-MS/MS method for the quantification of entecavir in human plasma and its application to bioequivalence study.
Topics: Analysis of Variance; Antiviral Agents; Area Under Curve; Chromatography, Liquid; Drug Stability; Guanine; Humans; Lamivudine; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency | 2011 |
Validation of a sensitive LC/MS/MS method for the determination of zidovudine and lamivudine in human plasma.
Topics: Chromatography, Liquid; Drug Stability; Humans; Lamivudine; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Zidovudine | 2012 |
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
Topics: Adenine; Anion Exchange Resins; Antiviral Agents; Calibration; Chromatography, Liquid; Deoxycytidine; Diphosphates; Emtricitabine; Humans; Lamivudine; Leukocytes, Mononuclear; Nucleosides; Organophosphonates; Phosphates; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir; Zidovudine | 2011 |
[A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Drug Monitoring; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Nucleotide Motifs; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Rapid identification of YVDD mutants of hepatitis B virus using smart amplification process with competition probe.
Topics: Antiviral Agents; Codon; DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Point Mutation; Sensitivity and Specificity; Sequence Analysis, DNA; Time Factors | 2011 |
A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.
Topics: Adenine; Chromatography, High Pressure Liquid; Drug Stability; Humans; Lamivudine; Linear Models; Male; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir | 2012 |
Exploring dried blood spot sampling technique for simultaneous quantification of antiretrovirals: lamivudine, stavudine and nevirapine in a rodent pharmacokinetic study.
Topics: Animals; Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Drug Stability; Lamivudine; Male; Nevirapine; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Stavudine; Tandem Mass Spectrometry | 2012 |
Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.
Topics: Adult; Antiviral Agents; China; Cohort Studies; Cost-Benefit Analysis; Drug Resistance, Viral; Drug Therapy, Combination; Emergency Treatment; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Markov Chains; Organophosphonates; Patient Simulation; Predictive Value of Tests; Quality-Adjusted Life Years; Sensitivity and Specificity; Viral Load | 2012 |
Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment.
Topics: Adult; Aged; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2002 |
Determination of lamivudine/stavudine/efavirenz in human serum using liquid chromatography/electrospray tandem mass spectrometry with ionization polarity switch.
Topics: Alkynes; Benzoxazines; Chromatography, High Pressure Liquid; Cyclopropanes; Humans; Lamivudine; Oxazines; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stavudine | 2002 |
[Factors predicting lack of adherence to highly active antiretroviral treatment].
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Data Collection; Drug Combinations; Drug Utilization Review; HIV Infections; Humans; Lamivudine; Outpatient Clinics, Hospital; Patient Compliance; Patient Dropouts; Registries; Sensitivity and Specificity; Spain; Treatment Refusal; Zidovudine | 2002 |
Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Humans; Lamivudine; Methionine; Mutation; Peptide Nucleic Acids; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Sequence Analysis, DNA | 2003 |
[Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 2003 |
A real-time quantitative polymerase chain reaction method for hepatitis B virus in patients with chronic hepatitis B treated with lamivudine.
Topics: Adult; Base Sequence; Cohort Studies; DNA Mutational Analysis; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genes, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Probability; Prognosis; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Statistics, Nonparametric | 2003 |
Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization.
Topics: Drug Resistance, Viral; Fluorescence Polarization; Genetic Testing; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2003 |
Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Amino Acid Motifs; Chronic Disease; Female; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Sequence Analysis, DNA | 2004 |
Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virus.
Topics: DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutagenesis, Site-Directed; Oligonucleotide Array Sequence Analysis; Oligonucleotide Probes; Sensitivity and Specificity | 2004 |
Simultaneous determination of zidovudine and lamivudine from rat plasma, amniotic fluid and tissues by HPLC.
Topics: Amniotic Fluid; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Female; Fetus; Half-Life; Lamivudine; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tissue Distribution; Zidovudine | 2004 |
Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Didanosine; Dideoxynucleosides; Drug Stability; HIV; HIV Infections; Humans; Lamivudine; Quality Control; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine | 2005 |
Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray.
Topics: Base Sequence; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Sensitivity and Specificity; Treatment Outcome; Viral Load | 2005 |
Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Treatment Outcome | 2005 |
Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR.
Topics: DNA Primers; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Point Mutation; Polymerase Chain Reaction; Prevalence; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Sweden | 2005 |
Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.
Topics: Adenine; Antiviral Agents; Cost-Benefit Analysis; Decision Support Techniques; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Markov Chains; Organophosphonates; Recombinant Proteins; Salvage Therapy; Sensitivity and Specificity; Transaminases | 2005 |
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.
Topics: Adenine; Antiviral Agents; Cost-Benefit Analysis; Decision Support Techniques; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Markov Chains; Organophosphonates; Recombinant Proteins; Salvage Therapy; Sensitivity and Specificity; Transaminases | 2005 |
Dual-probe assay for detection of lamivudine-resistance hepatitis B virus by real-time PCR.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA | 2006 |
Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance.
Topics: Antiviral Agents; Case-Control Studies; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Oligonucleotide Array Sequence Analysis; Sensitivity and Specificity | 2005 |
Hepatitis B virus DNA quantitation and detection of core promoter, precore and polymerase mutations in chronic hepatitis B: evaluation and clinical usefulness of three new commercial assays.
Topics: Adolescent; Adult; Antiviral Agents; Child; Computer Systems; DNA Mutational Analysis; DNA-Directed DNA Polymerase; DNA, Viral; Female; Genes, Viral; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Mutation, Missense; Point Mutation; Polymerase Chain Reaction; Promoter Regions, Genetic; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Sequence Analysis, DNA; Viral Load | 2005 |
Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method.
Topics: Amino Acid Motifs; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleic Acid Hybridization; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2005 |
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.
Topics: Adult; Aged; Cohort Studies; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Probability; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Viral Core Proteins | 2006 |
Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Drug Combinations; Lamivudine; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine | 2006 |
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
Topics: Adenine; Antiviral Agents; Base Sequence; DNA Probes; DNA, Viral; Drug Resistance, Viral; Genes, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; In Vitro Techniques; Lamivudine; Mutation; Organophosphonates; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Virology | 2006 |
Detection of YMDD mutants using universal template real-time PCR.
Topics: Antiviral Agents; Aspartic Acid; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Methionine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Tyrosine | 2006 |
Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia.
Topics: Adolescent; Adult; Age Factors; Aged; Antiviral Agents; Carrier State; Child; Child, Preschool; DNA Primers; DNA, Viral; Gambia; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Viral Load | 2006 |
Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.
Topics: Child, Preschool; China; Cost-Benefit Analysis; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Lamivudine; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Time Factors | 2006 |
Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients.
Topics: Adult; Antiviral Agents; DNA Probes; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Fluorometry; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Nucleic Acid Hybridization; Sensitivity and Specificity; Transition Temperature | 2006 |
Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment.
Topics: Amino Acid Motifs; Antiviral Agents; Cloning, Molecular; DNA Primers; Genes, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Viral Proteins | 2006 |
Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.
Topics: Adult; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2006 |
COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma.
Topics: Adenine; Antiviral Agents; Automation; Biopsy; DNA, Viral; Drug Resistance, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Nucleic Acid Amplification Techniques; Organophosphonates; Polymerase Chain Reaction; Sensitivity and Specificity; Taq Polymerase; Viremia | 2007 |
Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Topics: Adult; Amino Acid Substitution; Cell Line; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoenzyme Techniques; Lamivudine; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Protein Precursors; Radioimmunoassay; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Transfection; Treatment Outcome; Viremia | 2007 |
Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy.
Topics: Anti-HIV Agents; Drug Monitoring; HIV Infections; HIV-1; Immunoenzyme Techniques; Indinavir; Lamivudine; Sensitivity and Specificity; Time Factors; Virus Replication; Zidovudine | 2007 |
Real-time PCR detection of multiple lamivudine-resistant mutations with displacing probes in a single tube.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Serum; Statistics as Topic | 2007 |
Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
Topics: Anti-HIV Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Drug Contamination; Drug Evaluation, Preclinical; Lamivudine; Microchemistry; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical; Zidovudine | 2007 |
Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR.
Topics: Antiviral Agents; DNA Mutational Analysis; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Probes; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 2007 |
Cathodic adsorptive stripping voltammetric studies on lamivudine: an antiretroviral drug.
Topics: Adsorption; Anti-Retroviral Agents; Calibration; Chemistry, Pharmaceutical; Drug Design; Electrochemistry; Electrodes; Electrons; Equipment Design; Hydrogen-Ion Concentration; Lamivudine; Models, Chemical; Sensitivity and Specificity; Technology, Pharmaceutical | 2007 |
Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
Topics: Adult; Aged; Amino Acid Motifs; Codon; DNA Mutational Analysis; DNA-Directed DNA Polymerase; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome; Viral Load | 2007 |
Rapid and simple liquid chromatography tandem mass spectrometry method for the quantification of zidovudine in rat plasma.
Topics: Animals; Chromatography, High Pressure Liquid; Injections, Intravenous; Lamivudine; Methanol; Rats; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water; Zidovudine | 2008 |
Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk.
Topics: Chromatography, High Pressure Liquid; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Nevirapine; Postpartum Period; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine | 2007 |
An efficient tool for surveying CRF01_AE HIV type 1 resistance in Thailand to combined stavudine-lamivudine-nevirapine treatment: mutagenically separated PCR targeting M184I/V.
Topics: Anti-HIV Agents; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Nevirapine; Polymerase Chain Reaction; Sensitivity and Specificity; Stavudine; Thailand | 2007 |
Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B.
Topics: Drug Resistance, Viral; Genetic Testing; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Ligase Chain Reaction; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity | 2008 |
Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
Topics: Base Sequence; DNA Probes; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Reproducibility of Results; Sensitivity and Specificity; Taq Polymerase | 2008 |
Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
Topics: Antiviral Agents; DNA Primers; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity | 2008 |
The production and evaluation of a radioligand and antiserum for the radioimmunoassay of subnanogram per millilitre concentrations of lamivudine.
Topics: Animals; Cross Reactions; Immune Sera; Lamivudine; Ligands; Mass Spectrometry; Nucleotides; Radioimmunoassay; Sensitivity and Specificity; Sheep; Zalcitabine | 1994 |
High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
Topics: Antiviral Agents; Autoanalysis; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV Seropositivity; Hot Temperature; Humans; Lamivudine; Quality Control; Sensitivity and Specificity; Zalcitabine | 1994 |
Automated high-performance liquid chromatographic analysis of (-)-2'-deoxy-3'-thiacytidine in biological fluids using the automated sequential trace enrichment of dialysate systems.
Topics: Animals; Antiviral Agents; Autoanalysis; Body Fluids; Chromatography, High Pressure Liquid; Dialysis; Humans; Kidney; Lamivudine; Rats; Sensitivity and Specificity; Zalcitabine | 1994 |
Rapid quantitation of (-)-2'-deoxy-3'-thiacytidine in human serum by high-performance liquid chromatography with ultraviolet detection.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Stability; Humans; Lamivudine; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1997 |
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoenzyme Techniques; Interferons; Lamivudine; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity | 1997 |
Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.
Topics: Anti-HIV Agents; Codon; Didanosine; Drug Resistance, Microbial; Genes, pol; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Oligonucleotide Probes; Polymerase Chain Reaction; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, DNA; Zidovudine | 1998 |
Quantitative determination of (-)-2'-deoxy-3'-thiacytidine (lamivudine) in human plasma, saliva and cerebrospinal fluid by high-performance liquid chromatography with ultraviolet detection.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; HIV Infections; HIV-1; Humans; Lamivudine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Saliva; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Toxoplasmosis, Cerebral | 1998 |
Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 1999 |
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Taq Polymerase | 2000 |
Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
Topics: Anti-HIV Agents; Calibration; Chromatography, High Pressure Liquid; Cytidine Triphosphate; Dideoxynucleotides; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Mass Spectrometry; Monocytes; Reference Standards; Sensitivity and Specificity; Stavudine; Thymine Nucleotides; Zidovudine | 2000 |
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.
Topics: Antiviral Agents; Base Sequence; Cross-Sectional Studies; DNA Probes; Drug Resistance, Microbial; Evolution, Molecular; Genetic Variation; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Longitudinal Studies; Nevirapine; Nucleic Acid Heteroduplexes; Point Mutation; Reproducibility of Results; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Selection, Genetic; Sensitivity and Specificity | 2001 |
Limitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine.
Topics: Branched DNA Signal Amplification Assay; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2001 |
Real-time PCR for detection and quantitation of hepatitis B virus DNA.
Topics: Acute Disease; Antiviral Agents; Computers; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity | 2001 |
High-performance liquid chromatographic assay for the determination of 2'-deoxy-3'-thiacytidine (lamivudine) in human plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Lamivudine; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2001 |
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Viral Load | 2001 |
Absolute lymphocyte count as surrogate for CD4+ cell count in monitoring response to antiretroviral therapy.
Topics: Adolescent; Adult; Analysis of Variance; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lamivudine; Lymphocyte Count; Male; Middle Aged; Sensitivity and Specificity; Time Factors; Zidovudine | 2001 |
Real-time measurement of anti-HBs level and donor-specific transfusion via portal vein may reduce amount of HBIG after living related liver transplantation.
Topics: Graft Rejection; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Infusions, Intravenous; Lamivudine; Liver Transplantation; Living Donors; Portal Vein; Preoperative Care; Sensitivity and Specificity; Transplantation Immunology; Treatment Outcome | 2002 |
Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Reagent Kits, Diagnostic; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2002 |